日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A nomogram for predicting recurrence-free survival in patients with high-risk GIST receiving adjuvant imatinib: A nationwide registry study

用于预测接受伊马替尼辅助治疗的高危胃肠道间质瘤患者无复发生存期的列线图：一项全国性注册研究

期刊:
影响因子:
doi:10.3892/etm.2026.13140
Yeh, Chun-Nan; Shan, Yan-Shen; Yang, Ching-Yao; Hsiao, Chin-Fu; Tsai, Chung-Hsin; Wang, Chuan-Cheng; Lin, Ming-Tsan; Ting, Chun-Fu; Chan, De-Chuan; Chen, Te-Hung; Yen, Chueh-Chuan; Chen, Yen-Yang; Lin, Hsuan-Yu; Yeh, Ta-Sen; Ho, Ching-Liang; Shieh, Tze-Yu; Bai, Li-Yaun; Hsu, Jun-Te; Chen, I-Shu; Chen, Li-Tzong; Tsai, Hui-Jen
发表日期：2026
文献求助 收藏

Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study-TCOG T1214 study.

台湾胃肠胰神经内分泌肿瘤的临床结果：一项多中心注册研究——TCOG T1214 研究

期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.70019
Tsai Hui-Jen, Chen Ming-Huang, Wang Hsiu-Po, Hsiao Chin-Fu, Chen Yen-Yang, Chen Jen-Shi, Yang Mei-Due, Tzen Chin-Yuan, Shan Yan-Shen, Bai Li-Yaun, Chan De-Chuan, Chu Pei-Yi, Ho Ching-Liang, Yang Youngsen, Lin Johnson, Lin Hsuan-Yu, Chang Cheng-Shyong, Wang Chuan-Cheng, Hwang Tsann-Long, Chen Li-Tzong
免疫/内分泌
神经科学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

PCK2 promotes invasion and epithelial-to-mesenchymal transition in triple-negative breast cancer by promoting TGF-β/SMAD3 signaling through inhibiting TRIM67-mediated SMAD3 ubiquitination.

PCK2 通过抑制 TRIM67 介导的 SMAD3 泛素化来促进 TGF-β/SMAD3 信号传导，从而促进三阴性乳腺癌的侵袭和上皮间质转化

期刊:Cancer Biology & Therapy
影响因子:4.6
doi:10.1080/15384047.2025.2478670
Chang Tsung-Ming, Fang Wei-Yu, Hsu Hui-Ping, Chu Pei-Yi, Jiang Shih Sheng, Huang Kuo-Wei, Hung Wen-Chun, Lin Hui-You, Tsai Hui-Jen
肿瘤
乳腺癌
TGF-β
泛素化
发表日期：2025
文献求助 收藏

The Epidemiology of Neuroendocrine Carcinomas in Taiwan: A Population-Based Cancer Registry Study

台湾神经内分泌癌的流行病学：一项基于人群的癌症登记研究

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.71369
Yang, Yi-Hsin; Huang, Ru-Yu; Chu, Pei-Yi; Yang, Shuen-Ru; Du, Jeng-Shiun; Tsai, Hui-Jen
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

A phase I study of liposomal Irinotecan (ONIVYDE®) in combination with TAS-102 (LONSURF®) in refractory solid tumors

一项针对难治性实体瘤的脂质体伊立替康（ONIVYDE®）联合TAS-102（LONSURF®）的I期研究

期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-025-01547-2
Chiang, Nai-Jung; Bai, Li-Yuan; Ho, I-Wei; Hsu, Chih-Hung; Liang, Yi-Hsin; Chiu, Chang-Fang; Lin, Ching-Chan; Chang, Kwang-Yu; Chen, Shang-Hung; Tsai, Hui-Jen; Lin, Yu-Ping; Chen, Li-Tzong; Lin, Chia-Chi
发表日期：2025
文献求助 收藏

Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan

同源重组基因种系突变与胰腺癌临床结局：一项台湾多中心研究

期刊:Journal of Biomedical Science
影响因子:12.1
doi:10.1186/s12929-024-01008-7
Cheng, Siao Muk; Su, Yung-Yeh; Chiang, Nai-Jung; Wang, Chih-Jung; Chao, Ying-Jui; Huang, Chien-Jui; Tsai, Hui-Jen; Chen, Shang-Hung; Chang, Chi-Yen; Tsai, Chia-Rung; Li, Yi-Jie; Yen, Chia-Jui; Chuang, Shih-Chang; Chang, Jeffrey Shu-Ming; Shan, Yan-Shen; Hwang, Daw-Yang; Chen, Li-Tzong
肿瘤免疫
胰腺癌
肿瘤
发表日期：2024
文献求助 收藏

A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study

一项针对晚期上消化道肿瘤的每两周一次的nab-紫杉醇/奥沙利铂/S-1/LV方案的I期研究：TCOG T1216研究

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyae109
Tsai, Hui-Jen; Yang, Shih-Hung; Hsiao, Chin-Fu; Kao, Hsiang-Fong; Su, Yung-Yeh; Shan, Yan-Shen; Yen, Chia-Jui; Du, Jeng-Shiun; Hsu, Chiun; Wu, I-Chen; Chen, Li-Tzong
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study

台湾地区接受酪氨酸激酶抑制剂治疗的晚期/复发性胃肠道间质瘤患者的生存情况：一项全国性登记研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-024-12567-1
Tsai, Hui-Jen; Shan, Yan-Shen; Yang, Ching-Yao; Hsiao, Chin-Fu; Tsai, Chung-Hsin; Wang, Chuan-Cheng; Lin, Ming-Tsan; Ting, Chun-Fu; Chan, De-Chuan; Chen, Te-Hung; Yen, Chueh-Chuan; Chen, Yen-Yang; Lin, Hsuan-Yu; Yeh, Ta-Sen; Ho, Ching-Liang; Shieh, Tze-Yu; Bai, Li-Yaun; Hsu, Jun-Te; Chen, I-Shu; Chen, Li-Tzong; Yeh, Chun-Nan
信号转导
发表日期：2024
文献求助 收藏

Imatinib use for gastrointestinal stromal tumors among older patients in Japan and Taiwan

伊马替尼在日本和台湾老年患者中用于治疗胃肠道间质瘤

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-022-27092-z
Ichinose, Yuichi; Yang, Yi-Hsin; Tsai, Hui-Jen; Huang, Ru-Yu; Higashi, Takahiro; Nishida, Toshirou; Chen, Li-Tzong
发表日期：2022
文献求助 收藏

Phase I Dose-Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid Tumors

SCB01A（一种具有血管破坏活性的微管抑制剂）在晚期实体瘤患者中的 I 期剂量递增研究

期刊:Oncologist
影响因子:4.2
doi:10.1002/onco.13612
Shiah, Her-Shyong; Chiang, Nai-Jung; Lin, Chia-Chi; Yen, Chia-Jui; Tsai, Hui-Jen; Wu, Shang-Yin; Su, Wu-Chou; Chang, Kwang-Yu; Wang, Ching-Chiung; Chang, Jang-Yang; Chen, Li-Tzong
发表日期：2021
文献求助 收藏